^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners

    TEST:
    HEMEaccuTest™

    Company:
    NGeneBio
    Type:
    CE Marked
    Related tests:

    Details

    Evidence
    News
    HEMEaccuTest™, based on NGS, detects about 100 genetic mutations related to hematological malignant tumors in blood, hematopoietic organs, lymph nodes, and lymphoid organs, and helps to select the optimal treatment and treatment suitable for each patient.
    Cancer:
    Acute Lymphocytic Leukemia, Acute Myelogenous Leukemia, Lymphoma, Multiple Myeloma, Myelodysplastic Syndrome, Myeloproliferative Neoplasm
    Method:
    Next-Generation Sequencing (NGS)